Previous Article | Next Article ![]()
Applied and Environmental Microbiology, July 2006, p. 4811-4818, Vol. 72, No. 7
0099-2240/06/$08.00+0 doi:10.1128/AEM.00472-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Department of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, Iowa 50011-1250,1 Department of Agriculture and Biosystems Engineering, College of Agriculture, Iowa State University, Ames, Iowa 50011-12502
Received 27 February 2006/ Accepted 8 May 2006
|
|
|---|
|
|
|---|
A number of variables are known to affect impinger collection efficiency. These include impinger design (5, 13, 24), sampling time (28), and the composition of collection medium (31). In addition, specific compounds are sometimes added to impinger collection medium to preserve virus infectivity during the collection process (37, 38, 40).
This research focused on specific aspects of optimizing the collection and detection of aerosolized porcine reproductive and respiratory syndrome virus (PRRSV) and swine influenza virus (SIV) in air-sampling systems. The first study (experiment 1) focused on virus detection. Compounds added to collection media to enhance collection efficiency (i.e., antifoams, bovine serum albumin, gelatin, mucin, activated carbon, and ethylene glycol) were evaluated for direct effects on virus infectivity, on the viability of continuous cell lines used for the isolation of these viruses, and on the performance of reverse transcriptase PCR (RT-PCR) assays. The second study (experiment 2) focused on optimizing sampling parameters, including medium composition, impinger model, and sampling time, for the collection of PRRSV from aerosols.
|
|
|---|
Swine influenza virus.
A field isolate of SIV designated A/Swine/Iowa/73 (H1N1) (National Veterinary Service Laboratories, Ames, IA) was used in this study. The virus was propagated on Madin-Darby canine kidney (MDCK) cells.
Cell lines.
Virus propagation, microinfectivity assays, and neutral red (NR) cell viability assays were performed on MARC-145 and MDCK (American Type Culture Collection, Manassas, VA) continuous cell lines. Cells were propagated and maintained in 75-cm2 flasks (catalog no. 3150; Corning, Corning, NY). Growth medium for both cell lines consisted of minimal essential medium (MEM) (catalog no. M4655; Sigma Chemical Co., St. Louis, MO) supplemented with 10% fetal bovine serum (catalog no. F4922; Sigma, St. Louis, MO), 50 µg of gentamicin (catalog no. G1272; Sigma, St. Louis, MO) per ml, 0.25 µg of amphotericin B (Fungizone A2942; Sigma, St. Louis, MO) per ml, and 100 µg of penicillin-streptomycin (catalog no. P0781, Sigma; St. Louis, MO) per ml.
Virus titration.
Samples were titrated following the protocols described below. Virus titers were calculated using the Spearman-Kärber method (22) and expressed as 50% tissue culture infective dose (TCID50) per milliliter.
(i) PRRSV.
For PRRSV, 200 µl of MARC-145 cells suspended in MEM growth medium at a concentration of 4 x 105 cells per ml were added to each well of a 96-well plate (catalog no. 3596; Corning, Corning, NY). Plates were incubated at 37°C in a humidified 5% CO2 incubator until the cell monolayer was confluent. Samples were serially 10-fold diluted (100 to 105) in MEM. Growth medium was discarded, and four wells were inoculated with 100 µl of sample at each dilution. After incubating for 2 h, the inoculum was discarded and 200 µl of growth medium with reduced fetal bovine serum (5%) was added to each well. Plates were incubated at 37°C in a humidified 5% CO2 incubator for 48 h. Following incubation, cells were fixed with aqueous 80% acetone solution and stained with a fluorescein isothiocyanate-conjugated monoclonal antibody specific for PRRSV (SDOW17; Rural Technologies, Inc., Brookings, SD). Virus titers were calculated on the basis of the number of wells showing a PRRSV-specific fluorescence reaction at each dilution. Each sample was run in duplicate, and the titers were averaged.
(ii) Swine influenza virus.
For SIV, 200 µl of MDCK cells suspended in MEM growth medium at a concentration of 4 x 105 cells per ml were added to each well of a 96-well plate. Plates were incubated at 37°C in a humidified 5% CO2 incubator until cell monolayers were confluent. Treatment samples were serially 10-fold diluted (100 to 105) in inoculation medium. Inoculation medium consisted of MEM supplemented with 5% (vol/vol) bovine serum albumin (BSA) (catalog no. 15260-037; Invitrogen, Carlsbad, CA), 50 µg of gentamicin per ml, 0.25 µg of amphotericin B per ml, 100 µl per ml of 200 mM L-glutamine, and tosylsulfonyl phenylalanyl chloromethyl ketone (TPCK)-treated trypsin (catalog no. LS003740; Worthington Biochemical, Lakewood, NJ) at 4 µg per ml. Growth medium was discarded, and cells were rinsed three times with MEM containing TPCK-treated trypsin at 4 µg per ml. Four wells were inoculated with 100 µl of sample at each dilution, and then plates were incubated at 37°C in a humidified 5% CO2 incubator. After incubating for 2 h, the inoculum was discarded and 200 µl of the inoculation medium was added to each well. Plates were then incubated at 37°C in a humidified 5% CO2 incubator for 3 to 6 days. Cells were examined for cytopathic effects (CPE) daily. At day 6 or after the appearance of CPE, plates were fixed and stained as previously described by Clavijo et al. (8). The presence of SIV in cells was confirmed by an immunoperoxidase assay using a monoclonal antibody specific for influenza A virus nucleoprotein. Virus titers were determined by the number of wells at each dilution showing CPE and/or a positive reaction. Each sample was run in duplicate, and the titers averaged.
PCR.
PRRSV and SIV RNA for real-time RT-PCR amplification was extracted from 0.14 ml of sample with a QIAamp viral RNA mini kit (catalog no. 210210; QIAGEN Inc., Valencia, CA), following the protocols recommended by the manufacturer. Real-time RT-PCR quantification was performed using an ABI Prism 7900 HT sequence detection system (Applied Biosystems, Foster City, CA). Primers specific for ORF7 (PRRSV) and neuraminidase segment (SIV) were synthesized by Integrated DNA Technologies (Coralville, IA), and minor groove binder probes were synthesized by Applied Biosystems (Foster City, CA). The thermal profile for amplification of both PRRSV and SIV viral RNA was a reverse transcription at 50°C for 30 min, followed by enzyme activation at 95°C for 15 min, then 40 cycles of denaturation at 94°C for 15 s and a combined annealing/extension step at 60°C for 60 s. Fluorescence data capture occurred at the combined annealing/extension stage. For each assay, a standard curve was generated using standards (101 to 106 TCID50 equivalents per ml) and positive and negative control samples were tested with the unknowns. The unit expression for RT-PCR for PRRSV is TCID50/ml, which represents quantity of total viral RNA in samples relative to standards in which the amount of measurable infectious viruses was quantified using microtitration infectivity assays. Quantitative RT-PCR values are estimates of total viral RNA present in samples including both infectious and inactivated virus.
Experiment 1: effects of compounds on cell viability, virus infectivity, and PCR performance.
Specific compounds sometimes added to air-sampling collection media to improve collection efficiency were evaluated for direct effects on cell viability, virus infectivity, and quantitative RT-PCR assays specific for PRRSV and SIV.
Medium compounds.
Compounds tested included antifoams, protectants (BSA, gelatin, and mucin), sorbents (activated carbon), and ethylene glycol. Effects on cell viability were assessed by exposing MARC-145 and MDCK cells to these compounds for 2 h and then measuring differences between treated and untreated cells using a neutral red assay. Effects on virus infectivity were measured by exposing PRRSV and SIV to these compounds for 6 h at 37°C and then comparing pre- and postexposure titers (TCID50) to those of nonexposed controls. Effects on the diagnostic performance of quantitative RT-PCR assays were evaluated by comparing the PCR results from virus samples with and without these compounds. Compounds exhibiting no deleterious effects on cells, virus, or PCR assays were selected for further evaluation in experiment 2.
(i) Antifoams.
The process of impingement produces extensive foaming when the liquid collection medium contains proteins and/or carbohydrates. Antifoams are added to the collection medium to eliminate this problem (26, 37). Based on these reports, six antifoams (Sigma, St. Louis, MO), i.e., antifoam 204 (A6426), antifoam A emulsion (A5758), antifoam B emulsion (A5757), antifoam C emulsion (A8011), antifoam O-30 (A8082), and antifoam SE-15 (A8582), were evaluated. Although their exact compositions are proprietary information, this selection included both organic (antifoam 204 and antifoam O-30) and silicone-based (antifoam A, emulsion, antifoam B emulsion, antifoam C emulsion, and antifoam SE-15) antifoams. Antifoams were diluted in phosphate-buffered saline (PBS) (1x) to 0.01% (vol/vol) and tested for their effects on cell viability (neutral red assay), virus infectivity (TCID50), and diagnostic performance (RT-PCR).
(ii) Protectants.
The addition of BSA (38), mucin (35), and/or gelatin (38) to collection or suspension medium has been shown to reduce the rate of virus inactivation and preserve virus infectivity during the process of impingement or aerosolization. Based on these reports, solutions of BSA (A9418), gelatin (G1890), and mucin (M1788) (Sigma, St. Louis, MO) at a concentration of 1.0% (wt/vol) in PBS (1x) were examined for effects on cell viability (neutral red assay), virus infectivity (TCID50), and diagnostic performance (RT-PCR).
(iii) Sorbents.
Activated carbon adsorbs viruses (3, 9) and may enhance infectivity (7). Based on these reports, one peat-based (catalog no. C9157; Sigma, St. Louis, MO) and one wood-based (Cal-Pacific, Fields Landing, CA) activated carbon product were tested at five treatment levels (0.2, 1.0, 2.0, 10.0, and 20.0% [wt/vol]) in PBS (1x) for effects on cell viability (neutral red assay). Additionally, activated carbon (1.0%) was examined for effects on diagnostic performance (RT-PCR).
(iv) Ethylene glycol.
Although its use in collection media has not been described previously, ethylene glycol was evaluated because it offers the possibility of sampling at temperatures below 0°C (32°F), since the ethylene glycol freezing point is 13°C. A 20% solution of ethylene glycol (catalog no. 29,323-7; Sigma, St. Louis, MO) (vol/vol) in PBS (1x) was tested for effects on cell viability (neutral red assay), virus infectivity (TCID50), and diagnostic performance (RT-PCR). A 20% solution was selected to decrease the medium's freezing point to 8°C.
Neutral red cell viability assay.
An NR cell viability assay was used to quantify the direct effects of compounds on MARC-145 and MDCK cells (2). The quantity of dye taken up by cells was estimated using a spectrophotometer, and then the effect of each treatment was determined by comparing the absorbance value (cell viability) of treated wells to that of the untreated control wells.
In brief, the NR assay was performed by adding 200 µl of each compound at the concentrations to be tested (antifoams [0.1%], ethylene glycol [20%], and protectants [1.0%]) to 12 wells of a 96-well microtitration plate containing a 75% confluent monolayer of MARC-145 or MDCK cells. Each compound and concentration was tested eight times (eight plates). To account for plate-to-plate variability, all within-group treatments (antifoams, ethylene glycol, and protectants) and untreated controls (12 wells) were present on all plates. Cells were exposed to compounds for 2 h at 37°C in a 5% CO2-humidified incubator. Following exposure, compounds were discarded and replaced with maintenance medium. Plates were incubated for an additional 24 h at 37°C in a 5% CO2-humidified incubator. Following incubation, the medium was replaced with filtered (Millipore Super-Q, ZFSQ115P4 system with cartridge nos. CDMB01204, CDAC01204, CP2001003, and PMEG09002; Millipore, Billerica, MA) sterilized water containing 40 µg per ml of neutral red (N 2889; Sigma Chemical Co., St. Louis, MO). Plates were incubated for 3 h at 37°C in a 5% CO2-humidified incubator to allow for uptake of the dye. To remove the dye not taken up by living cells, the wells were rinsed with a sterile water solution containing 0.5% formaldehyde and 1% CaCl2. To extract the dye taken up by viable cells, 200 µl of 1% acetic acid and 50% ethanol in sterile water was added to each well. The plate was left to stand at ambient temperature for 5 min and then agitated on a microplate shaker for 30 min to ensure that the dye had been released from the cells and mixed into solution. The reaction was quantified using a spectrophotometer (model no. ELx800; BioTek Instruments, Inc., Winooski, VT) at a wavelength of 540 nm, and the results were reported as mean absorbance.
Virus infectivity and RT-PCR detection.
One-milliliter aliquots of stock virus (PRRSV and SIV) were added to 50 ml of collection medium (PBS) containing the compounds and concentrations to be tested (antifoams [0.1%], ethylene glycol [20%], BSA [1.0%], gelatin [1.0%], and mucin [1.0%]) in 250-ml medium bottles. Following the addition of virus, the collection medium compounds were incubated on a stir plate for 6 h at 37°C in a 5% CO2-humidified incubator. Samples were taken at 0 and 6 h, aliquoted, and stored frozen at 80°C. Each compound and concentration was tested three times. Microtitration infectivity assays and quantitative RT-PCRs were performed on all samples (concentration for each replicate) concurrently.
Experiment 2: effect of collection media, impinger, and sampling time on collection of aerosolized PRRSV.
The objective of experiment 2 was to optimize aerosol sampling parameters for collection of PRRSV. Collection medium (compounds selected for further evaluation from experiment 1), impinger model, and sampling time were evaluated relative to recovery of aerosolized PRRSV.
Aerosolization of PRRSV.
PRRSV diluted in PBS (1x) to a titer of 1 x 106.33 TCID50 was aerosolized using a 24-jet Collison nebulizer (model no. CN60; BGI, Inc., Waltham, MA) operated on compressed air (catalog no. 00916734000; Sears Roebuck, Hoffman Estates, IL) at 40 lb/in2 producing 80 liters of free air per minute. The aerosolized PRRSV flowed into a 5-gal glass reservoir (catalog no. B26; The Home Brewery, Inc., Ozark, MO), which was modified to allow simultaneous sample collection at six outlet ports (Fig. 1). Outlet ports were installed by drilling six equidistantly spaced holes at the circumference of the glass reservoir and permanently attaching a glass stem (inside diameter [ID], 0.5 in; length, 1.5 in) to each hole. Clear tubing (ID, 0.375 in; wall thickness, 0.125 in) (catalog no. 14-169-7H; Fisher Scientific, Hampton, NH) was used to connect the impingers to the outlet ports (Fig. 1). This arrangement made it possible to test up to six different treatments simultaneously on the same cloud of aerosolized PRRSV.
![]() View larger version (28K): [in a new window] |
FIG. 1. Illustration of the experimental design to optimize sampling time, collection media, and impingers for aerosolized PRRS virus. (A) Collison nebulizer. (B) Glass carboy. (C) AGI-30 impingers.
|
Sampling of aerosolized PRRSV. (i) Collection medium.
Six collection medium treatments were compared on the basis of recovery of aerosolized PRRSV from the reservoir. PBS (1x) was used as the diluent in all treatments. Medium treatments were PBS; PBS and 1% activated carbon (Cal-Pacific, Fields Landing, CA) (wt/vol); PBS and 0.5% BSA (wt/vol); PBS and 20% ethylene glycol (vol/vol); PBS, 0.5% BSA, and 1% activated carbon; and PBS, 20% ethylene glycol, 0.5% BSA, and 1% activated carbon (Table 1).
|
View this table: [in a new window] |
TABLE 1. Medium treatments examined for collection efficiency of aerosolized PRRS virus in experiment 2
|
(iii) Sampling time.
The effect of sampling time (0, 1, 2, 5, 10, 15, and 20 min) on the collection of aerosolized PRRSV was evaluated by medium treatment (n = 6) and impinger model (n = 3). For each replicate, each of six impingers of the identical model was filled with 20 ml of one of the six collection medium treatments to be tested. All six impingers sampled the same aerosol cloud for the designated sampling time, after which the collection fluid was harvested, aliquoted, and stored at 80°C. The experiment was repeated until each sampling time had been examined. The model was replicated three times for each of the three impinger models. A total of 63 experimental runs were completed with the six collection medium treatments (7 time points x 3 impinger models x 3 replications). Recovery of PRRSV was determined by quantitative RT-PCR. To reduce variability, RT-PCR was performed on the collection medium samples concurrently.
Statistical analysis.
Medium compound treatments evaluated in experiment 1 were compared by analysis of variance (ANOVA) (JMP; SAS Institute Inc., Cary, NC) using the data from the neutral red cell viability assays, microinfectivity assays, and quantitative RT-PCR assays. Results were reported as least square means. The null hypothesis stated that the means of the treatments and the means of the controls were equal. A significance level of <0.05 was used as the minimum acceptable P value. If the means were significantly different, individual pair-wise treatment comparisons were performed using Student's t test.
Quantitative RT-PCR data from collection medium treatments in experiment 2 were analyzed using repeated measures multivariate ANOVA (MANOVA) (JMP; SAS Institute Inc., Cary, NC) using sampling time as the repeating variable. The model included the main effects of impinger and collection media. Two-way and three-way interactions, i.e., impinger x time, collection media x time, impinger x collection media, and impinger x collection media x time, were included in the model. Results were reported as least square means. A significance level of <0.05 was required as the minimum acceptable P value. If the MANOVA was significant, one-way ANOVAs were performed at each time point. If the ANOVA was significant, individual pair-wise comparisons was performed at that time point using Student's t test.
|
|
|---|
|
View this table: [in a new window] |
TABLE 2. Univariate effects of antifoams, protectants, and ethylene glycol on viability of MARC-145 and MDCK cell lines as measured by the neutral red assay
|
|
View this table: [in a new window] |
TABLE 3. Univariate effects of antifoams, proteins, and ethylene glycol on virus infectivity and RT-PCR diagnostic performance
|
(iii) Sorbents.
Activated carbon was cytotoxic to cell lines at all concentrations tested. Therefore, it was only possible to test the direct effect of activated carbon on diagnostic performance (RT-PCR). The addition of a wood-based activated carbon product (Cal-Pacific, Fields Landing, CA) to the collection medium had no effect on quantitative RT-PCR values for PRRSV or SIV compared to those for controls (P > 0.05). The addition of peat-based activated carbon product (catalog no. C9157; Sigma, St. Louis, MO) significantly (P < 0.001) reduced quantitative RT-PCR values for PRRSV and SIV compared to those for controls. On the basis of the overall results, wood-based activated carbon (1.0%) was selected for use in experiment 2.
(iv) Ethylene glycol.
Exposure of both MARC-145 and MDCK cells to a 20% ethylene glycol solution significantly reduced cell viability (P < 0.05) compared to that of controls. The addition of ethylene glycol to collection media did not reduce the infectivity or inhibit quantitative RT-PCR for PRRSV or SIV relative to controls. On the basis of the overall results, ethylene glycol (20%) was selected for use in experiment 2.
Experiment 2: effect of collection media, impinger, and sampling time on collection of aerosolized PRRSV. (i) Aerosolization of PRRSV.
The concentration of PRRSV in the suspension fluid was measured during operation of the Collison nebulizer by sampling at intervals and then assaying the sample by quantitative RT-PCR (Fig. 2). The mean titer of PRRSV in the suspension fluid across sampling times was 1 x 106.33 TCID50. No difference was detected in the concentration of PRRSV when comparing the initial and subsequent samples across sampling times (P = 0.89). These results indicated that the concentration of aerosolized PRRSV was constant over the period of aerosolization.
![]() View larger version (6K): [in a new window] |
FIG. 2. Quantity of PRRSV in Collison nebulizer during operation.
|
![]() View larger version (9K): [in a new window] |
FIG. 3. Collection of aerosolized PRRSV by impinger.
|
![]() View larger version (13K): [in a new window] |
FIG. 4. Collection of aerosolized PRRSV by collection medium treatment.
|
(iii) Impingers.
As estimated by quantitative RT-PCR, the mean titers of PRRSV collected across all time points were 1 x 104.67, 1 x 104.53, and 1 x 104.30 TCID50 for the SCK BioSampler, AGI-30, and AGI-4 (6 liter), respectively. The SCK BioSampler and AGI-30 impingers collected a significantly greater amount of PRRSV than did the AGI-4 (6 liter) impinger at sampling times of 10, 15, and 20 min. At sampling times of 15 and 20 min, the SKC BioSampler collected a significantly greater amount of PRRSV than did the AGI-30 or AGI-4 (6 liter) (Fig. 3).
(iv) Sampling time.
As measured by quantitative RT-PCR, the total quantity of PRRSV collected by impingers increased as sampling time increased. The mean titers by sampling time across impinger and media were 1 x 100, 1 x 103.66, 1 x 103.93, 1 x 104.57, 1 x 104.74, 1 x 104.96, and 1 x 105.17 TCID50 for 0, 1, 2, 5, 10, 15, and 20 min, respectively (Fig. 5).
![]() View larger version (9K): [in a new window] |
FIG. 5. Aerosolized PRRS virus collected over time.
|
|
|
|---|
Collection media described for the recovery of airborne pathogens in air impingers are varied but include deionized water (30), buffered solutions (25), and mineral oil (31). Compounds added to collection medium to improve pathogen recovery include various proteins (38) and antifoaming agents (6, 23, 26, 37). However, the effect of collection medium composition on the recovery and detection of airborne viruses has not been quantified in direct comparisons.
Sampling times reported for the recovery of airborne pathogens using air impingers are variable, ranging from minutes to hours (12, 28, 29, 39). Likewise, flow rates described for the collection of airborne viruses are variable, ranging from 12.5 liters/min (14) to 450 liters/min (10). Counterintuitively, increased sampling time and/or flow rate does not necessarily result in an increase in the quantity of pathogen recovered. For example, foot-and-mouth disease virus was detected in 21 of 21 samples at a sampling time of 30 min but was detected in 0 of 4 samples at a sampling time of 4 h (33). Likewise, exotic Newcastle disease virus was detected in collection medium after 2 h of air sampling but not detected in collection medium after 8 h of air sampling (21). Possible explanations for a decrease in recovery and detection with longer sampling time include the destruction of infectious virus particles by shear forces during the process of impingement and/or reaerosolization (reentrainment) of captured particles. Lin et al. (31) hypothesized that the hydrophobic virus particles, i.e., enveloped viruses, may be reentrained more readily in liquid air impingers.
For the most part, the effects of component variables on the recovery of airborne viruses have not been systematically investigated. Our research examined specific component variables related to collection medium, sampling time, and impinger type in the context of the recovery and detection of PRRSV and SIV. Initially, various collection medium compounds were evaluated for their effects on the detection of infectious PRRSV and SIV. Subsequently, medium composition, impinger type, and sampling time were analyzed to optimize the recovery of aerosolized PRRSV.
In experiment 1, antifoams, activated carbons, protectants, and ethylene glycol were evaluated for direct effects on the infectivity of PRRSV and SIV, on the viability of continuous cell lines used for the isolation of these viruses, and on the performance of RT-PCR assays. Each compound tested was selected for a specific property related to the collection and/or detection of PRRSV and/or SIV: (i) antifoams are necessary to eliminate the excessive foaming that occurs during impingement when the collection medium contains proteins or carbohydrates (26, 37); (ii) activated carbon was evaluated for its potential to reduce reentrainment in impingers by adsorbing viral particles (32, 34, 36, 41); (iii) bovine serum albumin, mucin, and gelatin have been shown to reduce the rate of virus inactivation and preserve virus infectivity during the process of impingement or aerosolization (35, 38); and (iv) ethylene glycol was evaluated because it offered the possibility of collecting air samples at temperatures below 0°C.
The results of the first experiment showed that the addition of specific compounds to collection media can affect virus detection, i.e., the viability of continuous cell lines, virus infectivity, and/or performance of RT-PCR. These effects were not necessarily uniform within a group of compounds. For example, statistically significant differences were found among antifoams in their effect on continuous cell lines, with some antifoams exhibiting no effect on cells. Cytotoxic effects were not necessarily reflected in antiviral effects. Thus, although cytotoxic to cells, antifoams, protectants, and ethylene glycol had no effect on virus infectivity. The detection of PRRSV and SIV by RT-PCR was affected by the addition of protectants and activated carbon, but not antifoams or ethylene glycol. Overall, the variable effects of collection medium compounds on the detection of PRRSV and SIV demonstrated the need to examine each compound in the context of the compound's intended use in the air-sampling system and the pathogen of interest.
Questions related to the optimization of collection media remain. In particular, additional research on the use of activated carbon or other sorbents in collection medium is warranted. In this study, the addition of a peat-based activated carbon to collection medium significantly reduced the quantity of PRRSV and SIV detected by RT-PCR. Likewise, the addition of wood-based activated carbon reduced the quantity of PRRSV detected in impinger collection medium at all time points by RT-PCR. Activated carbon is known to adsorb viruses through nonspecific binding to viral surface proteins (7), but its effect on RT-PCR performance had not been described previously. The results in experiments 1 and 2 suggested two possibilities: activated carbons inhibited RT-PCR or virus was adsorbed to carbon but was rendered unavailable to RT-PCR assays under the conditions described in this experiment. If the latter is the case, then the possibility remains that activated carbons or other sorbents could increase collection efficiency by improving virus capture and/or reducing reentrainment by adsorption.
In experiment 2, the medium compounds selected in experiment 1 were evaluated in the context of recovery of aerosolized PRRSV in each of three impingers (AGI-30, AGI-4 [6 liter], and SKC BioSampler). The objective of experiment 2 was to optimize the quantity of virus recovered by manipulating the component variables of collection media, impinger model, and sampling time. To accomplish this, a method was introduced whereby direct comparisons among up to six independent treatments were possible. The validity of the comparisons was based upon the fact that all treatments sampled the same cloud of aerosolized virus. The results from the second experiment showed that the component variables of collection media, impinger model, and sampling time affected collection efficiency of aerosolized PRRSV. Specifically, the effects of impinger model and collection medium on recovery of PRRSV were consistent across sampling times. For example, the SKC BioSampler and AGI-30 impinger models recovered greater quantities of aerosolized PRRSV than the AGI-4 (6 liter) did at all sampling points. Likewise, PBS with ethylene glycol collection medium recovered the greatest quantity of PRRSV at each sampling time. As in experiment 1, the effects of collection media, impinger model, and sampling time on the recovery of PRRSV demonstrated the necessity to examine the effects of individual air-sampling variables on recovery of specific target pathogens.
Several points regarding these experiments are worth noting. First, the experiments focused on optimizing the recovery and detection of viral pathogens in aerosols. In general, this is an "underexplored" area of research, despite the commonly expressed fears of airborne spread of infectious agents. Second, this study described a method for direct comparisons of up to six treatments on total viral recovery. Although this simple method has not previously been described in the literature, it offers distinct advantages in terms of experimental efficiency and statistical validity. Third, it was demonstrated that a 20% solution of ethylene glycol collected the greatest quantity of aerosolized PRRSV, which suggests possible applications in sampling at temperatures below the freezing point. A review of the literature found no previous reports of the use of ethylene glycol in aerosol collection medium.
It should be noted that there are currently no standard methods for the recovery and detection of specific pathogens in aerosols. In the absence of standards, air-sampling protocols must be optimized and validated for each target pathogen. Results of the recovery and detection of the presence or absence of specific aerosolized pathogens made using unvalidated systems should be interpreted cautiously.
We are grateful to the virology staff and Karen Harmon of the Veterinary Diagnostic Laboratory, College of Veterinary Medicine, Iowa State University, for excellent technical assistance.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»